Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
Final Trades: PayPal, Meta, Abbvie and Snowflake
01:18pm, Friday, 28'th Mar 2025
The Investment Committee give you their top stocks to watch for the second half.
AbbVie Vs. Sanofi: Which Is The Better Investment Right Now
09:44am, Friday, 28'th Mar 2025
AbbVie and Sanofi occupy leading positions in the global immunology market. Each of them has advantages, as well as dark spots in the pipeline of drugs relative to the rival. In this article you will
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:05am, Thursday, 27'th Mar 2025
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025
08:30am, Wednesday, 26'th Mar 2025
Data for ABBV-969, a novel STEAP1/PSMA dual-targeted antibody-drug conjugate (ADC) in Phase 1 for advanced prostate cancer, will be presented in an oral presentation. Data to be presented on ABBV-514,
2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income
06:30am, Wednesday, 26'th Mar 2025
Equities haven't performed well this year due to a combination of factors. Macroeconomic tensions are at the top of that list.
5 Large Drug Stocks to Watch as Industry Recovers
07:50am, Tuesday, 25'th Mar 2025
Industry Description
AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why
06:50pm, Monday, 24'th Mar 2025
The latest trading day saw AbbVie (ABBV) settling at $209.17, representing a -0.4% change from its previous close.
AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
07:19am, Sunday, 23'rd Mar 2025
AbbVie Inc. NYSE: ABBV is trading near an all-time high after the company announced a licensing agreement with Gubra, a Danish company. The agreement pertains to Gubra's experimental weight loss drug,
2025 Dividend Kings: Strong Run Continues
12:59pm, Friday, 21'st Mar 2025
The Dividend Kings are outperforming the S&P 500 in 2025 by 4.57%. Top performers include National Fuel & Gas (+30.21%), Consolidated Edison (+22.66%), and AbbVie (+20.40%). Promising Dividend Kings i
My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys
09:40am, Thursday, 20'th Mar 2025
February investments fell below $1,000, mainly in BDCs like Owl Rock Capital and Ares Capital, boosting annual dividend income by $77. Dividend income hit a new February record of $505, up 5% Y/Y driv
Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends
09:31am, Thursday, 20'th Mar 2025
So, you want to invest in AbbVie (ABBV 0.14%) because it's a promising dividend-paying stock, and you also want to receive $1,000 per year in dividend income from it. How many shares should you buy?
3 Dividend Stocks to Buy for Reliable Passive Income
07:30am, Wednesday, 19'th Mar 2025
You'll need passive income to live well in retirement, especially with Social Security's uncertain future. The Office of Retirement and Disability Policy says Social Security's funds might run out by
Only Have $500? 3 No-Brainer Stocks to Buy Right Now
11:26am, Tuesday, 18'th Mar 2025
Forget the old adage “it takes money to make money.
ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
08:00am, Saturday, 15'th Mar 2025
Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with ELAHERE compared to chemotherapy in folate receptor alpha (FRα)-posit
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
05:51am, Friday, 14'th Mar 2025
Many investors view the healthcare sector as a safe haven when the stock market is turbulent. That's understandable.
